Mast Therapeutics (MSTX) Reports In-Line Q2 EPS
Get Alerts MSTX Hot Sheet
Join SI Premium – FREE
Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Culp, Inc. (CULP) Misses Q4 EPS by 12c
- NHC acquires 35 facilities from NHI for $560 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share